Publikationsdatenbank

The application, challenges, and advancement toward regulatory acceptance of digital toxicologic pathology:
results of the 7th ESTP International Expert Workshop (September 20-21, 2019) (2021)

Art

Zeitschriftenartikel / wissenschaftlicher Beitrag

Autoren

Schumacher, Vanessa L.

Aeffner, Famke

Barale-Thomas, Erio

Botteron, Catherine

Carter, Jonathan

Elies, Laëtitia

Engelhardt, Jeffery A.

Fant, Pierluigi

Forest, Thomas

Hall, Peter

Hildebrand, Deon

Klopfleisch, Robert (WE 12)

Lucotte, Thomas

Marxfeld, Heike

Mckinney, LuAnn

Moulin, Pierre

Neyens, Elizabeth

Palazzi, Xavier

Piton, Alain

Riccardi, Elena

Roth, Daniel R.

Rousselle, Serge

Vidal, Justin D.

Williams, Bethany

Quelle

Toxicologic pathology

Bandzählung: 49

Heftzählung: 4

Seiten: 720 – 737

ISSN: 0192-6233

Sprache

Englisch

Verweise

URL (Volltext): https://journals.sagepub.com/doi/10.1177/0192623320975841

DOI: 10.1177/0192623320975841

Pubmed: 33297858

Kontakt

Institut für Tierpathologie

Robert-von-Ostertag-Str. 15
14163 Berlin
+49 30 838 62450
pathologie@vetmed.fu-berlin.de

Abstract / Zusammenfassung

With advancements in whole slide imaging technology and improved understanding of the features of pathologist workstations required for digital slide evaluation, many institutions are investigating broad digital pathology adoption. The benefits of digital pathology evaluation include remote access to study or diagnostic case materials and integration of analysis and reporting tools. Diagnosis based on whole slide images is established in human medical pathology, and the use of digital pathology in toxicologic pathology is increasing. However, there has not been broad adoption in toxicologic pathology, particularly in the context of regulatory studies, due to lack of precedence. To address this topic, as well as practical aspects, the European Society of Toxicologic Pathology coordinated an expert international workshop to assess current applications and challenges and outline a set of minimal requirements needed to gain future regulatory acceptance for the use of digital toxicologic pathology workflows in research and development, so that toxicologic pathologists can benefit from digital slide technology.